Engagement and attrition in digital mental health: current challenges and potential solutions
- PMID: 40604240
- PMCID: PMC12223045
- DOI: 10.1038/s41746-025-01778-w
Engagement and attrition in digital mental health: current challenges and potential solutions
Abstract
In digital mental health engagement rates are consistently low, which may limit its effects. Using an international multidisciplinary consensus method, including lived experience expertise and a systematic review, we identified three key challenges: (i) lack of agreed metrics for engagement; (ii) lack of evidence on how better engagement improves outcomes; (iii) lack of standards for user involvement. Three potential solutions encompassed: (i) standardisation of frameworks for reporting engagement metrics and optimal doses of digital tools, (ii) measuring engagement with more precise reporting of outcomes, including potential harms; (iii) defining standards of user involvement (including appropriate diversity, and clinician as well as user input). Digital interventions have real potential in meeting the shortfall in service provision for mental health, but this will require focus on high quality research studies of the underlying mechanisms of engagement and optimal outcomes. Our findings identify and highlight the next best steps in this process.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: K.A.S., C.B., C.G.S., K.H., I.P., T.W., T.G., L.T., S.R. declare no competing interests. S.M.G. reports honoraria from Hexal, Angelini, and Tegus. PJU reports honoraria from Boehringer. E.A.H. reports honoraria from Angelini to attend the meeting at which this paper was discussed. E.A.H. receives occasional honoraria for keynotes and workshops, and royalties on 2 books. E.A.H. developed the ICTI intervention (ANEMONE™) and founded Afterimagery. AB. K.B. reports honoraria from Böhringer Ingelheim and from publishers and training institutes for workshops, books and lectures on psychotherapy. He is co-founder of two digital mental health start-ups. JK has shares in Portabiles HCT, Germany; reports advisory activities and honoraria from Angelini, Bial, Biogen, BMS, Celgene, Desitin, EverPharma, Lundbeck-Foundation, Medical Valley Digital Health Application Center, Novartis, RoxHealth, StreamedUp, Bauerfeind, Remepy. J.K. reports board activities for European national HTA bodies, Michael J Fox Foundation for Parkinson’s Research (MJFF), Bertelsmann Foundation, Germany, Hans Seidel Stiftung, Germany. AC has received research, educational and consultancy fees from INCiPiT (Italian Network for Paediatric Trials), CARIPLO Foundation, Lundbeck and Angelini Pharma. JT is the editor-in-chief of JMIR Mental Health and associate editor of npj Digital Medicine.
References
Grants and funding
- BRC-1215-20005/NIHR (National Institute for Health and Care Research) Oxford Health Biomedical Research Centre
- BRC-1215-20005/NIHR (National Institute for Health and Care Research) Oxford Health Biomedical Research Centre
- BRC-1215-20005/NIHR (National Institute for Health and Care Research) Oxford Health Biomedical Research Centre
LinkOut - more resources
Full Text Sources
